Scynexis (SCYX) Free Cash Flow (2013 - 2026)
Scynexis (SCYX) posted Free Cash Flow of -$8.1 million for Q1 2026, down 144.02% on a QoQ basis from $18.4 million in Q4 2025, and down 8.52% year-over-year from -$8.9 million in Q1 2025.
Scynexis (SCYX) Free Cash Flow (2013 - 2026) Analysis & Trends
Scynexis' Free Cash Flow history runs 14 years deep, the most recent figure standing at -$8.1 million for Q1 2026.
- Quarterly Free Cash Flow fell 8.52% year-over-year to -$8.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.9 million (up 78.45% YoY) and the FY2025 annual result came in at -$5.3 million, up 78.0% from the prior year.
- Free Cash Flow was -$8.1 million for Q1 2026 at Scynexis, down from $18.4 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $74.4 million in Q2 2023 and bottomed at -$22.8 million in Q4 2022.
- A 5-year average of -$3.4 million and a median of -$8.1 million in 2026 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 1606.3% — and 2023, when it surged 500.4%.
- Scynexis' Free Cash Flow stood at -$22.8 million in 2022, then soared by 66.08% to -$7.7 million in 2023, then dropped by 28.08% to -$9.9 million in 2024, then soared by 285.74% to $18.4 million in 2025, then tumbled by 144.02% to -$8.1 million in 2026.
- Business Quant data shows SCYX's Free Cash Flow at -$8.1 million in Q1 2026, $18.4 million in Q4 2025, and -$8.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | -8.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.10 Mn |
| Mar 31, 2026 | -8.10 Mn |
| Dec 31, 2025 | 18.40 Mn |
| Dec 31, 2025 | 18.40 Mn |
| Sep 30, 2025 | -8.72 Mn |
| Sep 30, 2025 | -8.72 Mn |
| Jun 30, 2025 | -7.50 Mn |
| Jun 30, 2025 | -7.50 Mn |
| Mar 31, 2025 | -7.47 Mn |
| Mar 31, 2025 | -7.47 Mn |
| Dec 31, 2024 | -9.91 Mn |
| Dec 31, 2024 | -9.91 Mn |
| Sep 30, 2024 | 765,000.00 |
| Sep 30, 2024 | 765,000.00 |
| Jun 30, 2024 | -10.86 Mn |
| Jun 30, 2024 | -10.86 Mn |
| Mar 31, 2024 | -4.01 Mn |
| Mar 31, 2024 | -4.01 Mn |
| Dec 31, 2023 | -7.74 Mn |
| Dec 31, 2023 | -7.74 Mn |